These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8853752)

  • 1. Review article: older systemic and newer topical glucocorticosteroids and the gastrointestinal tract.
    Thiesen A; Thomson AB
    Aliment Pharmacol Ther; 1996 Aug; 10(4):487-96. PubMed ID: 8853752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide in inflammatory bowel disease.
    Lamers CB; Wagtmans MJ; van der Sluys Veer A; van Hogezand RA; Griffioen G
    Neth J Med; 1996 Feb; 48(2):60-3. PubMed ID: 8819801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral budesonide therapy for steroid-dependent ulcerative colitis: a pilot trial.
    Keller R; Stoll R; Foerster EC; Gutsche N; Domschke W
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1047-52. PubMed ID: 9663828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Steroid-induced myopathy in left-sided ulcerative colitis. Successful treatment and continued therapy with the topical steroid budesonide].
    Caesar I; Gross V; Roth M; Andus T; Hohenberger W; Schölmerich J
    Med Klin (Munich); 1997 Jun; 92(6):358-62. PubMed ID: 9297069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral budesonide therapy for ulcerative colitis: a topical tale.
    Feagan BG
    Gastroenterology; 1996 Jun; 110(6):2000-2. PubMed ID: 8964430
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glucocorticosteroids: mechanism of action, pharmacological effects, pharmacokinetics and adverse effects].
    Tarchalska-Kryńska B
    Otolaryngol Pol; 1994; 48 Suppl 17():41-8. PubMed ID: 8090502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of P-glycoprotein 170 in nasal mucosa may be increased with topical steroids.
    Henriksson G; Norlander T; Zheng X; Stierna P; Westrin KM
    Am J Rhinol; 1997; 11(4):317-21. PubMed ID: 9292183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new steroids: clinical experience in ulcerative colitis.
    Jewell DP
    Mt Sinai J Med; 1990 Oct; 57(5):293-6. PubMed ID: 1710774
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
    Scott M; Malmsten LA; Thelin I
    Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans.
    Manso G; Baker AJ; Taylor IK; Fuller RW
    Eur Respir J; 1992 Jun; 5(6):712-6. PubMed ID: 1321056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Locally acting glucocorticoids in chronic intestinal inflammation].
    Lamers CB; van der Sluys Veer A; Wagtmans MJ; van Hogezand RA
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2533-5. PubMed ID: 7830800
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of 16 alpha, 17 alpha-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoids.
    Brattsand R; Thalén A; Roempke K; Källström L; Gruvstad E
    J Steroid Biochem; 1982 Jun; 16(6):779-86. PubMed ID: 7109581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: systemic and topical steroids in inflammatory bowel disease.
    Schölmerich J
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():66-74. PubMed ID: 15352897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A budesonide prodrug accelerates treatment of colitis in rats.
    Cui N; Friend DR; Fedorak RN
    Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis.
    Löfberg R; Danielsson A; Suhr O; Nilsson A; Schiöler R; Nyberg A; Hultcrantz R; Kollberg B; Gillberg R; Willén R; Persson T; Salde L
    Gastroenterology; 1996 Jun; 110(6):1713-8. PubMed ID: 8964395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adrenal cortex suppression attributed to the use of budesonide].
    van Leerdam FJ; van Leerdam ME
    Ned Tijdschr Geneeskd; 1994 Dec; 138(53):2676-7. PubMed ID: 7830820
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; Seow CH; Steinhart AH; Griffiths AM
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
    Thalén A; Brattsand R; Andersson PH
    Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide multi-matrix system formulation for treating ulcerative colitis.
    Prantera C; Scribano ML
    Expert Opin Pharmacother; 2014 Apr; 15(6):741-3. PubMed ID: 24484392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for future topical glucocorticoid development.
    Brattsand R; Särnstrand B
    Acta Derm Venereol Suppl (Stockh); 1989; 151():37-46; discussion 47-52. PubMed ID: 2624065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.